C4 Therapeutics
CCCC
#8153
Rank
A$0.49 B
Marketcap
A$3.75
Share price
1.64%
Change (1 day)
-0.83%
Change (1 year)

EPS for C4 Therapeutics (CCCC)

EPS in 2026 (TTM): A-$1.05

According to C4 Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.09. In 2025 the company made an earnings per share (EPS) of A-$2.05 an increase over its 2024 EPS that were of A-$2.28.

EPS history for C4 Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.05-48.97%
2025A-$2.05-9.93%
2024A-$2.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04 87.50%๐Ÿ‡บ๐Ÿ‡ธ USA